This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Exelead

Profile

Scientists are driven by powerful ideas to develop innovative molecules that can save lives, but to bring their drug to market, they must navigate pharmaceutical manufacturing, clinical trials, logistical complexities, and strict regulations. Exelead guides you through each step, so you can get your drug to patients that need it.


Exelead specializes in manufacturing lipid nanoparticle, liposomal, and pegylated formulations. We work with you to bring your drug from development to commercialization. Visit us at booth 523 to learn more.


Exelead has been acquired by MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany.

www.exeleadbiopharma.com